Share
))
HBO and The Ringer's Bill Simmons hosts the most downloaded sports podcast of all time, with a rotating crew of celebrities, athletes, and media staples, as well as mainstays like Cousin Sal, Joe House, and a slew of other friends and family members who always happen to be suspiciously available.
…
continue reading
Manage episode 522453519 series 3606990
Content provided by Interwell Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Interwell Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode of Kidney Health Connections, Dr. Katherine Tuttle, a leading nephrologist and researcher, explores the transformative advancements in chronic kidney disease (CKD) treatment. She discusses the revolutionary impact of SGLT2 inhibitors and GLP1 agonists, which have shifted the landscape from modestly effective therapies to groundbreaking treatments that significantly slow disease progression, reduce cardiovascular risks, and even prevent kidney failure. These innovations align seamlessly with value-based care models, offering both clinical and economic benefits.
Dr. Tuttle also highlights the potential of combination therapies and the critical role of implementation in maximizing patient outcomes. As Dr. Tuttle puts it, this is a monumental time in medicine, with the potential to conquer CKD and transform lives.
Tune in to gain practical insights, learn about the emerging wave of new therapies, and discover why early intervention and multidisciplinary collaboration are vital.
You can also watch all episodes of the podcast on our YouTube channel—be sure to subscribe and never miss an update!
Follow Us
- LinkedIn @Interwell Health
- YouTube @interwellhealth
Presented by Interwell Health
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
21 episodes
